Abstract:Several anti-viral drugs like those used to treat human immunodeficiency virus (HIV) infections have been associated with neurotoxicity or neurodevelopmental impairments following in utero exposures. The aim of this special issue was to provide an updated overview on this topic. The published articles explored the argument using classical in vitro and animal models, and new emerging tools like cerebral organoids, covering several aspects of the proposed topic.Monnerie and colleagues explored the possibility that elvitegravir (EGV), belonging to the integrase strand transfer inhibitor (INSTI) class of antiretroviral drugs, may contribute to white matter damage in people living with HIV. The authors used mature rat cerebral cortical oligodendrocyte cultures as an in vitro model and found that EVG reduced oligodendrocyte differentiation, particularly at later stages. They investigated the involved mechanisms and found that EVG modulated the expression of sterol regulatory elementbinding protein-1 and -2 (SREBP-1 and SREBP-2), major regulators of cellular lipid metabolism. Their modulation was accompanied by reduced expression of key enzymes involved in fatty acid synthesis, while cholesterol pathways seemed unaffected. In contrast, the INSTI raltegravir (RAL) had no effect on SREBP expression. Unexpectedly, the addition of palmitate, a fatty acid, to oligodendrocyte cultures did not prevent EVG-induced inhibition of oligodendrocyte differentiation, while addition of serum albumin did prevent these effects.Rodent models are often used to evaluate neuronal toxicity of antiretroviral drugs or HIV-associated insults, however experimental observations may consistently coincide with results from human neuronal models.To overcome this problem, Starr and colleagues established an in vitro model of human induced pluripotent stem cell (iPSC)-derived cortical glutamatergic neurons. The authors first characterized their model, then assessed the effects of EVG and RAL exposure. The authors previously demonstrated that EVG but not RAL was neurotoxic in primary rat neuroglial cultures and that its toxicity was driven by the activation of the integrated stress response (ISR) (Stern et al., 2018). Here, they did not observe toxicity with either drug, measured by microtubule-associated protein 2 (MAP2) staining. However, electrophysiological measures suggested sub-lethal damage. RNA expression analysis further revealed that both INSTIs downregulated genes involved in extracellular matrix interaction, cell motility and morphogenesis.LaNoce and colleagues described the use of human iPSC-based forebrain organoids as models of human early cortical development to explore the effect of the INSTIs dolutegravir (DTG) and RAL. Previously, this model was successfully used to study the effects of Zika virus on neurodevelopment (Qian et al., 2016).Researchers treated early-stage cortical organoids with DTG or RAL within the range of cord blood concentrations. DTG exposure resulted in reduced organoid size and density of neural rosette structures and increased caspase-3 staining, while RAL had no appreciable effects. The authors performed RNA expression analyses on treated organoids and found that DTG exposure resulted in the upregulation of cellular stress, response to glucose starvation and amino acid stimulus pathways and downregulation of pathways involved in neuron differentiation and migration, CNS development and neuroblast proliferation.Immuno-histological analysis revealed reduced neurogenesis with fewer neural stem cells and postmitotic neurons. Further, they demonstrated that DTG induced ISR activation with the upregulation of downstream effectors, which may disrupt cell cycle progression and impair neurogenesis.A three-dimensional stem cell-derived brain organoid developmental model was also employed by Caiaffa and colleagues to analyze the effect of DTG with or without folic acid (FA) exposure in the earliest maturation stages. RNA expression analysis revealed that DTG exposure modulated the expression of genes involved in neurodevelopment, cell cycle, extracellular matrix, and membrane and motor proteins, as well as inducing the expression of the folate receptor FOLR1. FA exposure in the presence of DTG attenuated the alteration of gene expression, suggesting a protective role of FA. Using multimodal optical instruments, the authors found that organoids exposed to DTG presented biomechanical alterations like higher surface stiffness, lower internal stiffness and decreased volume during maturation, that were not rescued or mitigated by FA supplementation.Foster and colleagues evaluated safety and benefits of injectable long-acting DTG nano-formulation (NDTG) on fetal neurodevelopment compared to daily oral administration of native DTG in pregnant mice. The authors found that intramuscular injection of NDTG achieved therapeutic plasma DTG concentrations in pregnant dams. These pl -Abstract Truncated-

Neurotoxicity caused by didanosine on cultured dorsal root ganglion neurons

Insulin-Like Growth Factor-1 Prevents Dorsal Root Ganglion Neuronal Tyrosine Kinase Receptor Expression Alterations Induced by Dideoxycytidine in Vitro

Excessive Na+/H+ Exchange in Disruption of Dendritic Na+ and Ca2+ Homeostasis and Mitochondrial Dysfunction Following in Vitro Ischemia

Mitochondrial alterations with mitochondrial DNA depletion in the nerves of AIDS patients with peripheral neuropathy induced by 2'3'-dideoxycytidine (ddC)

Cisplatin-induced DNA-platination in experimental dorsal root ganglia neuronopathy

Toxicity of levodopa and dopamine on cultured rat mesencephalic cells

The Protective Effects of Igf-1 on Different Subpopulations of Drg Neurons with Neurotoxicity Induced by Gp120 and Dideoxycytidine in Vitro

Nmda Receptors Participate in the Progression of Diabetic Kidney Disease by Decreasing Cdc42-Gtp Activation in Podocytes

Dids Protects Against Neuronal Injury by Blocking Toll-Like Receptor 2 Activated-Mechanisms

Editorial: Antiviral drugs: neurotoxicity and neurodevelopmental effects

Influence of chronic oxaliptatin neurotoxicity on Nissl bodies and substance P in dorsal root ganglion

Tri-ortho-cresyl phosphate induces axonal degeneration in chicken DRG neurons by the NAD+ pathway

126-OR: Differences of Three-Dimensional Pathology of Dorsal Root Ganglia in Neuropathy of Type 1 and Type 2 Diabetes Mellitus

Chemotherapy-induced peripheral neuropathy in a dish: dorsal root ganglion cells treated in vitro with paclitaxel show biochemical and physiological responses parallel to that seen in vivo

Inhibition of tetrodotoxin-resistant sodium current in dorsal root ganglia neurons mediated by D1/D5 dopamine receptors

VDAC1 Protein Regulation of Oxidative Damage and Mitochondrial Dysfunction-Mediated Cytotoxicity by Silica Nanoparticles in SH-SY5Y Cells

PREVALENCE OF DIDANOSINE-RELATED RETINAL TOXICITY AT AN URBAN ACADEMIC CENTER AS DIAGNOSED WITH ULTRA-WIDEFIELD IMAGING

Folate deficiency and homocysteine induce toxicity in cultured dorsal root ganglion neurons via cytosolic calcium accumulation

Glycidol induces axonopathy and aberrations of hippocampal neurogenesis affecting late-stage differentiation by exposure to rats in a framework of 28-day toxicity study

40. Inflammatory Bowel Disease Affects Neuronal Survival in the Dorsal Motor Nucleus of the Vagus

Pyridoxine-induced toxicity in rats: a stereological quantification of the sensory neuropathy